Fundraising Fox
/Companies
Sign in

AEON Biopharma

NYSE: AEON

1 known investors

Find your way into AEON Biopharma

Sign up to see every warm intro you have to AEON Biopharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AEON Biopharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.

BiotechHealthtechMedical Devices

Founders & leadership

RB
Robert BancroftPresident, Chief Executive Officer and Director
JBJohn Bencich
John BencichChief Financial OfficerJohn Bencich is Chief Financial Officer at AEON Biopharma, which develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for neuromuscular disorders. He brings 25 years of experience in life sciences and biotechnology, with expertise in corporate strategy, capital raising, mergers and acquisitions, and financial leadership across early-stage companies and NASDAQ-listed firms.
COChad Oh
Chad OhChief Medical OfficerChief Medical Officer at Aeonbiopharma
AWAlex Wilson
Alex WilsonChief Legal & Strategy Officer; Corporate SecretaryHe previously practiced mergers and acquisitions, corporate governance, and capital markets law at O'Melveny & Myers LLP, and served as Chief Legal Officer at Glaukos Corporation, handling securities law, intellectual property, regulatory matters, and corporate transactions.
JSJennifer Sy
Jennifer SyChief Accounting OfficerJennifer Sy holds a B.A. in Business Economics with a minor in Accounting from UCLA and has spent over 18 years in finance and accounting roles across healthcare, technology, and consumer services, including positions as Corporate Controller at Nogin (where she led a SPAC IPO and ERP implementation), Director of Finance at Prospect Medical Holdings overseeing 16+ hospitals and clinics, and external auditor at Deloitte.

Investors · 1

Related companies · 3

Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Companies working in the same space as AEON Biopharma.

Frequently asked questions

What does AEON Biopharma do?
AEON Biopharma develops botulinum toxin biosimilars and therapeutic neurotoxin treatments for patients with neuromuscular disorders. The company focuses on expanding access to high-quality neurotoxin therapies through proprietary drug development.
Who are AEON Biopharma's investors?
AEON Biopharma's investors include Longitude Capital.